Prelude Therapeutics Incorporated
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Last updated:

Abstract:

The disclosure is directed to compounds of Formula I ##STR00001## Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.

Status:
Grant
Type:

Utility

Filling date:

5 Aug 2020

Issue date:

22 Feb 2022